Medtech Insights

The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…

The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…

The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…

Rising demand for neurovascular procedures – driven by expanding patient populations, the launch and increasing adoption of new devices backed by favorable clinical data and increasing…

The Asia Pacific TEO device market will experience moderate growth through 2033. This growth will be driven by the introduction and rising adoption of new devices supported by favorable clinical…

Driven by the increasing prevalence of ear, nose, and throat disease and patient awareness of ENT procedures in this region, the Asia Pacific ENT device market will continue to expand through 2033…

The Asia Pacific market for aortic repair device market will expand rapidly over the forecast period, driven primarily by endovascular procedure volume growth and continued development and adoption…

The Asia Pacific EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Asia Pacific countries, improved…

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…

The Asia Pacific heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Positive clinical outcomes supporting THV devices and the…

The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, expanding PAD-related comorbidities, and rising adoption of premium-priced drug-…

The Asia Pacific laparoscopic device market will experience modest growth through 2033. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…